Federal Register / Vol. 76, No. 57 / Thursday, March 24, 2011 / Rules and Regulations 16533 

entry for ‘‘060307’’ and in numerical 

sequence, add an entry for ‘‘066794’’ to 

read as follows: 

§ 510.600 Names, addresses, and drug 

labeler codes of sponsors of approved 

applications. 

* * * * * 

(c) * * * 

(1) * * * 

Firm name and address Drug labeler 

code 

* * * * * 

Piramal Critical Care, Inc., 3850 

Schelden Circle, Bethlehem, 

PA 18017 .............................. 066794 

* * * * * 

(2) * * * 

Drug 

labeler 

code 

Firm name and address 

* * * * * 

066794 .... Piramal Critical Care, Inc., 3850 

Schelden Circle, Bethlehem, 

PA 18017. 

* * * * * 

PART 529—CERTAIN OTHER DOSAGE 

FORM NEW ANIMAL DRUGS 

■ 3. The authority citation for 21 CFR 

part 529 continues to read as follows: 

Authority: 21 U.S.C. 360b. 

§ 529.1186 [Corrected] 

■ 4. In paragraph (b) of § 529.1186, 

remove ‘‘060307, and 065085’’ and in its 

place add ‘‘065085, and 066794’’. 

§ 529.2150 [Corrected] 

■ 5. In paragraph (b) of § 529.2150, 

remove ‘‘060307’’ and in its place add 

‘‘066794’’. 

Dated: March 17, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–6795 Filed 3–23–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Part 529 

[Docket No. FDA–2010–N–0002] 

Certain Other Dosage Form New 

Animal Drugs; Detomidine; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Correcting amendment. 

SUMMARY: The Food and Drug 

Administration (FDA) published a 

document in the Federal Register of 

April 23, 2010 (75 FR 21162), that 

amended the animal drug regulations to 

reflect approval of an original new 

animal drug application (NADA). FDA 

is correcting a paragraph describing 

limitations to the approved conditions 

of use for detomidine hydrochloride 

oromucosal gel in horses. This 

correction is being made to improve the 

accuracy of the animal drug regulations. 

DATES: This rule is effective March 24, 

2011. 

FOR FURTHER INFORMATION CONTACT: 

George K. Haibel, Center for Veterinary 

Medicine (HFV–6), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–276–9019, email: George.Haibel@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: FDA 

published a document in the Federal 

Register of April 23, 2010 (75 FR 

21162), that amended the animal drug 

regulations to reflect approval of an 

original NADA. FDA is correcting a 

paragraph describing limitations to the 

approved conditions of use for 

detomidine hydrochloride oromucosal 

gel in horses. This correction is being 

made to improve the accuracy of the 

animal drug regulations. 

List of Subjects in 21 CFR Part 529 

Animal drugs. 

Accordingly, 21 CFR part 529 is 

corrected by making the following 

correcting amendment: 

PART 529—CERTAIN OTHER DOSAGE 

FORM NEW ANIMAL DRUGS 

■ 1. The authority citation for part 529 

continues to read as follows: 

Authority: 21 U.S.C. 360b. 

■ 2. In § 529.536, amend paragraph 

(c)(3) by adding a sentence after the first 

sentence to read as follows: 

§ 529.536 Detomidine. 

* * * * * 

(c) * * * 

(3) * * * Do not use in horses 

intended for human consumption. 

Dated: March 17, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–6791 Filed 3–23–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Part 558 

[Docket No. FDA–2010–N–0002] 

Animal Drugs, Feeds, and Related 

Products; Withdrawal of Approval of 

New Animal Drug Applications; 

Aklomide; Levamisole Hydrochloride; 

Nitromide and Sulfanitran; Roxarsone; 

Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Correcting amendment. 

SUMMARY: The Food and Drug 

Administration (FDA) published a 

document in the Federal Register of 

October 26, 2010 (75 FR 65565) 

amending the animal drug regulations. 

The October 26, 2010, final rule 

amended the regulations by removing 

those portions that reflect approval of 

eight new animal drug applications. The 

final rule inadvertently failed to add 

conforming amendments in § 558.530. 

FDA is correcting the animal drug 

regulations by removing cross references 

for use of the withdrawn drugs in 

combination drug medicated feed. This 

correction is being made to improve the 

accuracy of the animal drug regulations. 

DATES: This rule is effective March 24, 

2011. 

FOR FURTHER INFORMATION CONTACT: 

George K. Haibel, Center for Veterinary 

Medicine (HFV–6), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–276–9019, 

e-mail: george.haibel@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The Food 

and Drug Administration (FDA) 

published a document in the Federal 

Register of October 26, 2010 (75 FR 

65565) amending the animal drug 

regulations. The October 26, 2010, final 

rule amended the regulations by 

removing those portions that reflect 

approval of eight new animal drug 

applications. The final rule 

inadvertently failed to add conforming 

amendments in § 558.530. FDA is 

correcting the animal drug regulations 

by removing cross references for use of 

the withdrawn drugs in combination 


jdjones on DSK8KYBLC1PROD with RULES
16534 Federal Register / Vol. 76, No. 57 / Thursday, March 24, 2011 / Rules and Regulations 

drug medicated feed. This correction is 

being made to improve the accuracy of 

the animal drug regulations. 

List of Subjects in 21 CFR Part 558 

Animal drugs, Animal feeds. 

Accordingly, 21 CFR part 558 is 

corrected by making the following 

correcting amendment: 

PART 558—NEW ANIMAL DRUGS FOR 

USE IN ANIMAL FEEDS 

■ 1. The authority citation for 21 CFR 

part 558 continues to read as follows: 

Authority: 21 U.S.C. 360b, 371. 

§ 558.530 [Corrected] 

■ 2. In § 558.530, remove and reserve 

paragraphs (d)(4)(i) and (d)(4)(xvii). 

Dated: March 17, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–6790 Filed 3–23–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Part 558 

[Docket No. FDA–2010–N–0002] 

New Animal Drugs for Use in Animal 

Feeds; Florfenicol; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Correcting amendments. 

SUMMARY: The Food and Drug 

Administration (FDA) published a 

document in the Federal Register of 

June 17, 2010 (75 FR 34361) revising the 

animal drug regulations to reflect 

approval of a supplemental new animal 

drug application (NADA). That 

document contained an incorrect table 

entry describing the maximum 

florfenicol concentration in Type B 

medicated swine feeds. This correction 

is being made to improve the accuracy 

of the animal drug regulations. 

DATES: This rule is effective March 24, 

2011. 

FOR FURTHER INFORMATION CONTACT: 

George K. Haibel, Center for Veterinary 

Medicine (HFV–6), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–276–9019, email: george.haibel@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The Food 

and Drug Administration (FDA) 

published a document in the Federal 

Register of June 17, 2010 (75 FR 34361) 

revising the animal drug regulations to 

reflect approval of a supplemental new 

animal drug application (NADA). That 

document contained an incorrect table 

entry describing the maximum 

florfenicol concentration in Type B 

medicated swine feeds. This correction 

is being made to improve the accuracy 

of the animal drug regulations. 

List of Subjects in 21 CFR Part 558 

Animal drugs, Animal feeds. 

Accordingly, 21 CFR part 558 is 

corrected by making the following 

correcting amendments: 

PART 558—NEW ANIMAL DRUGS FOR 

USE IN ANIMAL FEEDS 

■ 1. The authority citation for 21 CFR 

part 558 continues to read as follows: 

Authority: 21 U.S.C. 360b, 371. 

§ 558.4 [Corrected] 

■ 2. In paragraph (d) of § 558.4, in the 

‘‘Category II’’ table, in the ‘‘Type B 

maximum (100x)’’ column, in the entry 

for ‘‘Florfenicol’’, remove ‘‘Swine feed: 

n/a’’, ‘‘Catfish feed: n/a’’, and ‘‘Salmonid 

feed: n/a’’ and in their places add ‘‘9.1 

g/lb (2.0%)’’. 

Dated: March 17, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–6789 Filed 3–23–11; 8:45 am] 

BILLING CODE 4160–01–P 

POSTAL SERVICE 

39 CFR Parts 111 and 121 

Combined Mailings of Standard Mail 

and Periodicals Flats 

AGENCY: Postal Service.TM

ACTION: Final rule; withdrawal. 

SUMMARY: The Postal Service is 

withdrawing a final rule that would 

have provided a new option for mailers 

to combine mailings of Standard Mail ®

flats and Periodicals flats within the 

same bundle, when placed on pallets, 

and to combine bundles of Standard 

Mail flats and bundles of Periodicals 

flats on the same pallet. The Postal 

Service also withdraws the Code of 

Federal Regulations revision to reflect 

that Standard Mail service standards 

apply to all Periodicals flats pieces 

entered in such combined mailings. 

DATES: The final rule published on 

February 28, 2011 (76 FR 10757), is 

withdrawn effective March 24, 2011. 

FOR FURTHER INFORMATION CONTACT: 

Jonathan Leon at 202–268–7443, or 

Kevin Gunther at 202–268–7208. 

SUPPLEMENTARY INFORMATION: In a final 

rule published in the Federal Register 

on February 28, 2011, the Postal Service 

provided a new option for mailers to 

combine Standard Mail flats and 

Periodicals flats, when bundled and 

placed on pallets. Mailers using this 

option would have combined differentclass mailpieces within the same bundle 

(comail), or combined separate sameclass bundles (of different classes) on 

the same pallet (copalletize) to 

maximize presorting or to qualify for 

deeper destination entry discounts. All 

mailpieces prepared under this option 

were required to be bundled and placed 

on pallets. 

In consideration of concerns 

expressed by members of the mailing 

community, the Postal Service has 

elected to withdraw this final rule and 

will publish these standards as a 

proposed rule concurrently. 

The Postal Service also withdraws the 

revision to 39 CFR part 121.2 whereby 

we added a new item ‘‘c’’ to describe the 

USPS processing of Periodicals 

mailpieces included in combined 

mailings of Standard Mail flats and 

Periodicals flats, and specifying that 

Periodicals mailpieces included in these 

mailings will be assigned the service 

standards applicable to Standard Mail 

pieces. 

Stanley F. Mires, 

Chief Counsel, Legislative. 

[FR Doc. 2011–6911 Filed 3–23–11; 8:45 am] 

BILLING CODE 7710–12–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

40 CFR Part 261 

[EPA–R03–RCRA–2010–0132; FRL–9285–7] 

Hazardous Waste Management System 

Identification and Listing of Hazardous 

Waste; Final Exclusion 

AGENCY: Environmental Protection 

Agency. 

ACTION: Final rule. 

SUMMARY: The Environmental Protection 

Agency (EPA, also the Agency or we in 

this preamble) today is granting a 

petition submitted by Babcock & Wilcox 

Nuclear Operations Group, Inc., the 

current owner, and to BWX 

Technologies, Inc., as predecessor in 

interest to the current owner, identified 

collectively hereafter in this preamble as 

‘‘B&W NOG,’’ to exclude (or delist) on a 

one-time basis from the lists of 

hazardous waste, a certain solid waste 

generated at its Mt. Athos facility near 

Lynchburg, Virginia. 

After careful analysis, we have 

concluded that the petitioned waste is 


jdjones on DSK8KYBLC1PROD with RULES